Alterity Therapeutics Limited (ATHE)

NASDAQ: ATHE · IEX Real-Time Price · USD

1.799

-0.101 (-5.32%)

At close: Jul 19, 2024, 4:00 PM

1.780

-0.019 (-1.06%)

Pre-market: Jul 22, 2024, 5:47 AM EDT

Alterity Therapeutics Cash Flow Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Year Ending	TTM	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	2018 - 2000
Net Income	-12.28	-13.81	-12.85	-15.31	-13.46	-12.34	Upgrade
Other Operating Activities	-2.32	-6.23	0.51	-2.02	4.03	-1.62	Upgrade
Operating Cash Flow	-14.61	-20.04	-12.34	-17.33	-9.43	-13.95	Upgrade
Capital Expenditures	-0.01	-0.01	-0.09	-0.01	-0.02	-0.01	Upgrade
Other Investing Activities	-0.03	-0.03	-	-	-	-	Upgrade
Investing Cash Flow	-0.04	-0.04	-0.09	-0.01	-0.02	-0.01	Upgrade
Share Issuance / Repurchase	1.56	0.32	17.18	39.24	4.36	13.08	Upgrade
Debt Issued / Paid	-0.09	-0.06	-0.03	-0.06	-0.09	0	Upgrade
Other Financing Activities	-0.31	-0.13	-0.84	-2.49	-0.29	-0.36	Upgrade
Financing Cash Flow	1.16	0.12	16.3	36.69	3.98	12.72	Upgrade
Exchange Rate Effect	0.46	0.91	2.81	-0.43	0.26	0.4	Upgrade
Net Cash Flow	-13.48	-19.95	3.88	19.35	-5.47	-1.24	Upgrade
Free Cash Flow	-14.61	-20.04	-12.43	-17.34	-9.45	-13.96	Upgrade
Free Cash Flow Per Share	-3.59	-4.95	-3.10	-6.13	-6.33	-13.60	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).